Valuation: DreamCIS, Inc.

Market Cap 82.66B 59.74M 51.2M 47.9M 43.79M 82.63M 5.72B 83.51M 567M 220M 2.87B 224M 219M 9.5B P/E 2026 *
8.42x
P/E 2027 * 6.26x
Enterprise Value 39.66M 28.66K 24.56K 22.98K 21.01K 39.65K 2.74M 40.07K 272K 106K 1.38M 108K 105K 4.56M EV / Sales 2026 *
0.44x
EV / Sales 2027 * 0.27x
Free-Float
30.37%
Yield 2026 *
-
Yield 2027 * -
05-14 DreamCIS, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
03-23 DreamCIS, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
12-02 Curi Bio, Inc. announced that it has received $10 million in funding from DreamCIS, Inc. CI
11-11 DreamCIS, Inc. agreed to acquire 13.01% stake in Curi Bio, Inc. CI
11-11 Curi Bio, Inc. announced that it expects to receive $14.848537 million in funding from DreamCIS, Inc. CI
30/09/25 DreamCIS, Inc. announced that it has received KRW 15 billion in funding from Hong Kong Tigermed Co., Ltd., NH Investment & Securities Co., Ltd., KB Securities Co., Ltd., Korea Investment & Securities Co., Ltd. CI
22/09/25 DreamCIS, Inc. announced that it expects to receive KRW 15 billion in funding from Hong Kong Tigermed Co., Ltd., NH Investment & Securities Co., Ltd., KB Securities Co., Ltd., Korea Investment & Securities Co., Ltd. and other investors CI
22/02/24 Curi Bio, Genetox and DreamCIS Sign MOU for Strategic Collaboration on 3D Neuromuscular Junction Model for Botox Potency Assay CI
22/12/23 T&R Biofab Co., Ltd. announced that it has received KRW 1.999996 billion in funding from Korea Investment Partners Co. Ltd., DreamCIS, Inc. CI
14/12/23 T&R Biofab Co., Ltd. announced that it expects to receive KRW 1.999996 billion in funding from Korea Investment Partners Co. Ltd., DreamCIS, Inc. CI
22/03/23 DreamCIS, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
28/03/22 DreamCIS, Inc. announced that it has received KRW 2.9999925 billion in funding CI
17/03/22 DreamCIS, Inc. announced that it expects to receive KRW 2.9999925 billion in funding CI
1 day+2.91%
1 week-6.15%
Current month+18.73%
1 month+17.07%
3 months-41.57%
6 months-47.42%
Current year-47.34%
1 week 3,170
Extreme 3170
3,550
1 month 2,360
Extreme 2360
3,640
Current year 2,360
Extreme 2360
8,640
1 year 2,360
Extreme 2360
8,640
3 years 2,360
Extreme 2360
9,750
5 years 2,360
Extreme 2360
9,750
10 years 2,360
Extreme 2360
9,750
Manager TitleAgeSince
Chief Executive Officer 56 30/03/2022
Director of Finance/CFO 57 01/05/2016
Director TitleAgeSince
Director/Board Member 45 30/08/2019
Director/Board Member 57 01/05/2016
Director/Board Member 53 30/08/2019
Date Insider Type Main position Quantity % Market Cap.
12/16/24 A Buy

Chief Executive Officer

30,000 0.1261%
Change 5-day change 1-year change 3-year change Capi.($)
+2.91%-6.15%+1.20%-3.59% 59.74M
-1.30%+4.31%+97.90%+491.02% 47.24B
+0.89%+4.95%+21.99%+59.70% 27.52B
-4.66%-11.21%-15.26%-35.88% 7.58B
-2.77%-1.63%+6.55%+135.91% 5.88B
+1.77%+0.73%+14.01%+73.76% 3.29B
-2.15%+10.08%-33.79%+1,933.17% 2.54B
-3.36%+1.55%+148.45%+19.26% 2.11B
-5.17%+2.34%-5.83%-51.98% 2.05B
-0.59%+2.37%+30.68%+21.93% 1.96B
Average -1.45%+1.78%+26.59%+264.33% 10.02B
Weighted average by Cap. -1.07%+3.24%+54.62%+304.28%

Financials

2026 *2027 *
Net sales 90B 65.05M 55.75M 52.15M 47.68M 89.97M 6.23B 90.93M 617M 240M 3.13B 244M 239M 10.35B 117B 84.45M 72.38M 67.71M 61.9M 117M 8.09B 118M 801M 312M 4.06B 317M 310M 13.43B
Net income 9.8B 7.08M 6.07M 5.68M 5.19M 9.8M 678M 9.9M 67.19M 26.13M 341M 26.59M 26.02M 1.13B 13.2B 9.54M 8.18M 7.65M 6.99M 13.2M 913M 13.34M 90.51M 35.19M 459M 35.82M 35.04M 1.52B
Net Debt -43B -31.08M -26.63M -24.92M -22.78M -42.99M -2.98B -43.44M -295M -115M -1.49B -117M -114M -4.94B -51B -36.86M -31.59M -29.55M -27.02M -50.98M -3.53B -51.53M -350M -136M -1.77B -138M -135M -5.86B
Logo DreamCIS, Inc.
DreamCIS Inc is a Korea-based company principally engaged in the business of contract clinical trial. The Company mainly provides services include regulatory post-marketing surveillance (rPMS), clinical trial, non-interventional study (NIS) and others. The Company provides its services within domestic market and to overseas markets.
Employees
391
Date Price Change Volume
24/08/26 ₩3,360.00 +2.91% 42,377
21/08/26 ₩3,265.00 -2.25% 53,654
20/08/26 ₩3,340.00 +1.06% 51,071
19/08/26 ₩3,305.00 -2.51% 47,793
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A223250 Stock